IRVINE, Calif., April 9, 2009 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced the launch of an additional model of its SenoSonix(tm) System. Like the original SenoSonix, the new model is an integration of SenoRx’s EnCor(r) breast biopsy system with ultrasound imaging. This new version of the device incorporates a microminiaturization ultrasound technology that combines personal computing power and flexibility. The new ultrasound component is designed, developed and manufactured by Terason, a division of Teratech Corporation, based in Burlington, Massachusetts. This versatile and unique ultrasound technology coupled with SenoRx’s proprietary EnCor vacuum-assisted biopsy technology results in an attractive alternative model of the SenoSonix System for our customers. The modular design and sophisticated imaging architecture are now available in a reduced footprint with increased portability. The SenoSonix System received 510(k) clearance in October 2007 and CE Mark approval in April 2008.
